Calif. Justices Back Gilead Over Nondefective Drug Liability
The California Supreme Court on Monday held that Gilead Sciences Inc. shouldn't face a negligence claim alleging it declined to market a safer HIV drug in order to maximize profits from...To view the full article, register now.
Already a subscriber? Click here to view full article